- Report
- April 2026
- 137 Pages
Global
From €2691EUR$2,999USD£2,298GBP
€3588EUR$3,999USD£3,065GBP
- Report
- August 2025
- 130 Pages
Europe
From €3589EUR$4,000USD£3,065GBP
- Report
- January 2026
- 190 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- August 2026
- 307 Pages
Global
From €6276EUR$6,995USD£5,361GBP
- Report
- June 2026
- 216 Pages
Global
From €4441EUR$4,950USD£3,794GBP
- Report
- February 2026
- 172 Pages
Global
From €4172EUR$4,650USD£3,564GBP
- Report
- September 2025
- 125 Pages
Global
From €4172EUR$4,650USD£3,564GBP
- Report
- June 2026
- 200 Pages
Global
From €2683EUR$2,990USD£2,291GBP
- Report
- January 2026
- 326 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- September 2025
- 131 Pages
Global
From €4396EUR$4,900USD£3,755GBP
- Report
- January 2026
- 150 Pages
Global
From €5338EUR$5,950USD£4,560GBP
- Report
- May 2026
- 150 Pages
Global
From €5338EUR$5,950USD£4,560GBP
- Report
- October 2025
- 120 Pages
Global
From €5338EUR$5,950USD£4,560GBP
- Report
- January 2026
- 191 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- May 2026
- 180 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- January 2026
- 185 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP
- Report
- February 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,441GBP

Biomarker Analytics is a rapidly growing field within the larger field of Biomarkers. It involves the use of advanced analytics to identify, measure, and interpret biological markers in order to gain insights into the health of individuals and populations. This includes the use of data from clinical trials, medical records, and other sources to identify biomarkers that can be used to diagnose and treat diseases. Biomarker Analytics also involves the development of predictive models to identify individuals at risk for certain diseases and to monitor the progression of diseases.
The Biomarker Analytics market is driven by the increasing demand for personalized medicine and the need for more accurate and cost-effective diagnostics. Companies in this market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more